Solid organ transplantation (SOT) is a life-saving procedure and an established treatment for
patients with end-stage organ failure. However, transplantation is also accompanied by …

Post‐transplant diabetes mellitus (PTDM) shows a relationship with risk factors including
obesity and tacrolimus‐based immunosuppression, which decreases pancreatic insulin …

CHAIR: Costanzo MR: Midwest Heart Foundation, Lombard Illinois, USA TASK FORCE 1:
Dipchand A: Hospital for Sick Children, Toronto Ontario, Canada; Starling R: Cleveland …

A consensus meeting was held in Vienna on September 8–9, 2013, to discuss diagnostic
and therapeutic challenges surrounding development of diabetes mellitus after …

DIRECT (Diabetes Incidence after Renal Transplantation: Neoral C 2 Monitoring Versus
Tacrolimus) was a 6-month, open-label, randomized, multicenter study which used …

Although advances in immunosuppression, tissue ty**, surgery, and medical
management have made transplantation a routine and preferred treatment for patients with …

Although renal transplantation ameliorates cardiovascular risk factors by restoring renal
function, it introduces new cardiovascular risks including impaired glucose tolerance or …

Adipose tissue de novo lipogenesis (DNL) positively influences insulin sensitivity, is reduced
in obesity, and predicts insulin resistance. Therefore, elucidating mechanisms controlling …

Despite substantial improvement in short-term results after kidney transplantation, increases
in long-term graft survival have been modest. A significant impediment has been the …

A diagnosis of new-onset diabetes after transplantation (NODAT) carries with it a threat to
the renal allograft, as well as the same short-and long-term implications of type 2 diabetes …